Abstract
This article presents the results of anti-IgE-therapy in children with severe persistent uncontrolled atopic bronchial asthma. The clinical course of the disease during 3 years of follow-up was analyzed. The effectiveness of IgE-therapy was evaluated by the frequency of hospitalizations, asthma control, and changes in baseline therapy. Treatment with Omalizumab resulted in decreased frequency of acute states, normalized external respiration function, reduced severity of co-morbid pathology in the form of allergic rhinitis and atopic dermatitis.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
